Lung cancer histologic type in the surveillance, epidemiology, and end results registry versus independent review.
about
Comparison of aspects of smoking among the four histological types of lung cancerLong-term use of supplemental multivitamins, vitamin C, vitamin E, and folate does not reduce the risk of lung cancerPrevious lung diseases and lung cancer risk: a pooled analysis from the International Lung Cancer ConsortiumAn Overview of the North American Residential Radon and Lung Cancer Case-Control StudiesUtility of death certificate data in predicting cancer incidence.Lung cancer stage at diagnosis: Individual associations in the prospective VITamins and lifestyle (VITAL) cohort.Gene Expression Signature Differentiates Histology But Not Progression Status of Early-Stage NSCLC.Lung cancer and hormone replacement therapy: association in the vitamins and lifestyle studySurvival by histologic subtype in stage IV nonsmall cell lung cancer based on data from the Surveillance, Epidemiology and End Results ProgramAdenosquamous versus adenocarcinoma of the pancreas: a population-based outcomes analysis.From the bench to bedside: biological and methodology considerations for the future of companion diagnostics in nonsmall cell lung cancer.Use of glucosamine and chondroitin and lung cancer risk in the VITamins And Lifestyle (VITAL) cohort.Pathologic validation of renal cell carcinoma histology in the Surveillance, Epidemiology, and End Results programFolate receptor alpha expression in lung cancer: diagnostic and prognostic significance.Combined small-cell lung carcinoma: An institutional experienceNon-steroidal anti-inflammatory drugs and endometrial cancer risk in the VITamins And Lifestyle (VITAL) cohort.Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma.Non-steroidal anti-inflammatory drugs and small cell lung cancer risk in the VITAL studyEndometrial stromal sarcoma: a population-based analysisAssociations of long-chain ω-3 fatty acids and fish intake with endometrial cancer risk in the VITamins And Lifestyle cohort.Personalized medicine for lung cancer: new challenges for pathology.FDG-PET/CT response evaluation during EGFR-TKI treatment in patients with NSCLC.The Surveillance, Epidemiology, and End Results (SEER) Program and Pathology: Toward Strengthening the Critical Relationship.Validation of interobserver agreement in lung cancer assessment: hematoxylin-eosin diagnostic reproducibility for non-small cell lung cancer: the 2004 World Health Organization classification and therapeutically relevant subsets.Relationship between tumour size and outcome in pancreatic ductal adenocarcinoma.Validation for histology-driven diagnosis in non-small cell lung cancer using hsa-miR-205 and hsa-miR-21 expression by two different normalization strategies.Neither inadequacy of biopsy nor inaccuracy of reporting predict non-response to small-cell carcinoma chemotherapy.Genetic testing for lung cancer: reflex versus clinical selection.Temporal trends in liver-directed therapy of patients with intrahepatic cholangiocarcinoma in the United States: a population-based analysis.Cancers of the ampulla of vater: demographics, morphology, and survival based on 5,625 cases from the SEER program.Comparative analyses of overall survival in patients with anaplastic lymphoma kinase-positive and matched wild-type advanced nonsmall cell lung cancer.Alcohol consumption and risk of lung cancer in the VITamins And Lifestyle Study.Critical evaluation of the American Joint Commission on Cancer (AJCC) 8th edition staging system for patients with Hepatocellular Carcinoma (HCC): A Surveillance, Epidemiology, End Results (SEER) analysis.Assessment of the American Joint Commission on Cancer 8th Edition Staging System for Patients with Pancreatic Neuroendocrine Tumors: A Surveillance, Epidemiology, and End Results analysis.Long-Term, Supplemental, One-Carbon Metabolism-Related Vitamin B Use in Relation to Lung Cancer Risk in the Vitamins and Lifestyle (VITAL) Cohort.Risk factors for lung cancer in Iowa women: implications for prevention.LSCC SNP variant regulates SOX2 modulation of VDAC3.Molecular classification of nonsmall cell lung cancer using a 4-protein quantitative assayA Combined Analysis of North American Case-Control Studies of Residential Radon and Lung CancerRaman Spectroscopy for Clinical Oncology
P2860
Q24615517-C2125CC1-C861-4FFA-9F87-04D8F69C94DCQ24641973-2ED6810D-3656-4DDD-B9F9-28AF34E8A152Q28392363-54E71869-6273-4CC8-8FBF-040C0D006C11Q29028305-B2EE1327-E1E2-421C-9ED7-A4B7DF57109FQ30666980-633E91BE-A72F-4668-974C-5F45EEDD8A8BQ31016924-69B69ECE-AEC8-4E63-BAF9-96C97449F7CFQ33611881-7F2823AB-F767-453F-80F8-8C2822A02A92Q33770389-D6554DF5-745A-42AF-AF75-6716B81DB7E0Q33909900-AE703A35-A760-4D4A-AA60-7BADF0194F8FQ34501012-666CDF48-581E-479B-8940-43A024DA564EQ35117568-4615F428-F2D1-4247-83A2-E7C32AFDB932Q35220305-361BBB9E-8E2C-4D3E-A96D-9BDCDC7B1D2FQ35619923-BE8E8EF7-EC9D-43C6-8FBA-5A5FE563F75FQ36050687-96DBC201-AF20-4715-8F46-D5378DD73C65Q36439290-A639A033-B509-4C6A-9094-2FCB7C8064B7Q36501753-A82174AE-4C6E-4CA0-9511-E6A04C1D51E0Q36547246-9B7AED12-70D1-46C1-A69C-F798FCC436DFQ36555136-E53E8A9F-C153-4CA2-972D-614935F0EDE3Q36943983-52B7D313-EA2B-4114-91FC-602739D575B4Q37590642-A2B73B25-33D6-4052-9427-6397B6716450Q37932029-2157338C-CE5B-4B2C-B9E3-D237524176FBQ38234978-B3D029D0-9E34-4CD2-BE3C-7A5BEA2B0581Q38980532-6E9DF3F1-F982-4526-838E-16CA1A227E45Q39617870-F08E09CC-98D3-49E5-B364-3EF2AEC65494Q40344810-59EEA020-1AC0-4C83-B173-35FF59CEA63BQ40603527-0E4DCCF5-A434-4E79-A76C-36C6FBB0678AQ42835014-73730B86-53E0-4E64-98CF-20212D4A62EDQ42919827-19713705-F3AC-49B7-82A0-A5FD07D302B4Q44905186-CDFBC7D5-2B3A-43DE-8CFC-E307DB56C554Q44936944-0F2C56AA-6156-4560-9427-8FDD3D7C3992Q45770152-36B1AB60-F94B-4992-BE9E-24B380050500Q46424905-23BC5B2F-C060-454F-B8BF-B5DF7305A8E7Q47614432-65CDA2E0-3757-4EC3-8C75-98A5D921FDA2Q48143840-E607A550-92F7-4D69-A195-3534B24F72D5Q50498630-65E7E513-C959-4039-9E9D-6E0F6C7C0899Q51812449-20E242F5-F05C-40B0-9F97-95B5B9D7BCC0Q55259892-3020F39F-19C6-4557-8798-D46273EDDA7BQ56795277-2ABB12FD-9C35-4C03-BDA6-E35D68F4DD7AQ57420274-FDF96312-64F4-49FB-98E9-439F673CE4B1Q58655044-8E5B1453-0889-44B5-9E6E-289864DBBDB0
P2860
Lung cancer histologic type in the surveillance, epidemiology, and end results registry versus independent review.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Lung cancer histologic type in ...... try versus independent review.
@ast
Lung cancer histologic type in ...... try versus independent review.
@en
type
label
Lung cancer histologic type in ...... try versus independent review.
@ast
Lung cancer histologic type in ...... try versus independent review.
@en
prefLabel
Lung cancer histologic type in ...... try versus independent review.
@ast
Lung cancer histologic type in ...... try versus independent review.
@en
P2093
P356
P1476
Lung cancer histologic type in ...... try versus independent review.
@en
P2093
Neuberger JS
Robinson RA
P304
P356
10.1093/JNCI/DJH189
P407
P577
2004-07-01T00:00:00Z